Accordingly, Nijkamp and colleagues [44] demonstrated a potential correlation between the loss of E-cadherin and the presence of vimentin, indicating increased migratory capabilities in tumor cells and an increased risk of metastasis in patients with HNSCC. This evidence concerns the gene CDH1 and head and neck squamous cell carcinoma.